Treatments for childhood anaplastic large cell lymphoma
The following are treatment options for childhood anaplastic large cell lymphoma (ALCL). The healthcare team will suggest treatments based on your child’s needs and work with you to develop a treatment plan. Treatments are often based on the stage.
Sometimes childhood ALCL develops only in the skin. This is called cutaneous ALCL. It may be treated with surgery, radiation therapy or both. Sometimes chemotherapy with low-dose methotrexate is also given.
First-line therapy for childhood ALCL
First-line therapy is the first or most common treatment used. The following may be used as first-line therapy for ALCL.
Chemotherapy is the main treatment for childhood ALCL. How long chemotherapy is given and the combinations of drugs given depend on whether the ALCL is ALK-positive or ALK-negative and the stage of the cancer. Chemotherapy for low-stage (stage 1 and 2) ALCL may be given for 3–6 months. Chemotherapy for high-stage (stage 3 and 4) ALCL may be given for 9–12 months.
Chemotherapy drugs are given in different combinations based on different treatment plans (called protocols). The most common chemotherapy drugs used in combinations for ALCL are:
- doxorubicin (Adriamycin)
- cyclophosphamide (Cytoxan, Procytox)
- vincristine (Oncovin)
- mercaptopurine (Purinethol, 6-MP)
- cytarabine (Cytosar, Ara-C)
- dexamethasone (Decadron, Dexasone)
- etoposide (Vepesid, VP-16)
- ifosfamide (Ifex)
- leucovorin (folinic acid)
- vinblastine (Velbe)
- daunorubicin (Cerubidine, daunomycin)
- L-asparaginase (Kidrolase)
- 6-thioguanine (Lanvis, 6-TG)
Intrathecal chemotherapy may be given to prevent spread of NHL to the brain and spinal cord (called the central nervous system, or CNS) or to treat NHL that has spread to the CNS. This means that the drugs are given directly into the cerebrospinal fluid (CSF) around the brain and spinal cord. Intrathecal chemotherapy can include 1 to 3 of the following drugs:
Recurrent childhood ALCL
Some chemotherapy drugs and combinations used for recurrent ALCL include:
- dexamethasone, etoposide, cisplatin (Platinol AQ), cytarabine and L-asparaginase
- ifosfamide, carboplatin (Paraplatin, Paraplatin AQ) and etoposide
- crizotinib (Xalkori)
- brentuximab vedotin (Adcetris)
Many children with childhood ALCL will be treated in a clinical trial that is tailored to the risk group or stage of their disease. The clinical trial protocol, or plan, outlines the treatments used (such as chemotherapy), as well as the drugs and dosages used. Find out more about clinical trials.
Referring to DNA, cells, tissues or organs taken (harvested) from a donor to be given to a recipient who is a close, but not identical, genetic match.
For example, an allogeneic stem cell transplant takes blood or bone marrow from a donor (usually a first-degree relative) and gives it to a recipient.
Referring to DNA, cells, tissues or organs taken (harvested) from a person’s own body to be stored and given back to the same person.
For example, in an autologous stem cell transplant, blood or bone marrow is taken from a person, stored and later given back to the same person.
Autologous transplant is also called autotransplant or autograft.
Taking action against all cancers
The latest Canadian Cancer Statistics report found that of all newly diagnosed cancers in 2017, half are expected to be lung, colorectal, breast and prostate cancers. Learn what you can do to reduce the burden of cancer.